文献速递临床试验与 GCP流行病学与生物统计

适应性试验中估计目标考量的系统综述

Investigating estimand considerations in adaptive trials: a systematic review.
PubMed 文献 · Trials · 2026-02-06

该系统综述检索2023年发表在《BMJ Open》和《Trials》上的2至4期适应性设计随机对照试验方案与统计分析计划,共纳入146篇文章,其中仅5篇(3%)报告主要估计目标,3篇(2%)报告全部五项估计目标属性,94篇(64%)描述至少一个伴发事件,无文章为计划期中分析指定估计目标或考虑适应性对主要估计目标的影响。

要点

  • 146篇适应性设计随机对照试验文章中仅5篇(3%)报告主要估计目标。
  • 仅3篇(2%)报告全部五项估计目标属性。
  • 无文章为计划期中分析指定估计目标或考虑适应性对主要估计目标的影响。

核心结论

  • 本综述提供证据表明随机对照试验中对估计目标框架的采用仍然不足。
  • 更广泛地应用估计目标框架将确保临床试验结果报告和解读的清晰性。
  • 需要对如何将估计目标框架应用于适应性设计试验提供明确指导。

研究设计与样本

  • 系统综述,检索2023年发表在《BMJ Open》和《Trials》两本期刊上的随机对照试验方案和统计分析计划。
  • 纳入标准为涉及2至4期适应性设计试验的文章。
  • 使用预先试用的数据提取表提取研究详情、伴发事件和估计目标相关数据。

主要发现

  • 146篇符合纳入标准的文章中,5篇(3%)报告了主要估计目标。
  • 5篇报告主要估计目标的文章中,3篇(2%)报告了全部五项估计目标属性。
  • 94篇(64%)文章描述了一个或多个伴发事件,共描述232个伴发事件。
  • 52篇(36%)文章未描述任何伴发事件。
  • 无文章为任何计划期中分析指定估计目标,也无文章考虑适应性对主要估计目标的影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Randomised controlled trials (RCTs) are the gold standard for evaluating treatment effects, with the results informing policy and clinical practice. To ensure appropriate methods are utilised and to avoid misinterpretation of the results of a clinical trial, it is vital that we understand the research question a trial aims to answer. However, there is often ambiguity in how trialists define their research questions. In 2019, an addendum to the international trial regulatory guidelines (ICH E9 (R1)) introduced the estimand framework to combat this. A review of protocols published in 2020 investigated the early adoption of the estimand framework and found no uptake as well as a lack of clarity on key items such as the handling of intercurrent events. The aim of this review was to identify the current application of the estimand framework specifically to trials with an adaptive design. METHODS: The search strategy aimed to identify trial protocols and statistical analysis plans that described RCTs published in two journals (BMJ Open and Trials) in 2023. Articles were eligible if they related to phase 2-4 trials with an adaptive design. A pre-piloted data extract form was used to extract data relating to study details, intercurrent events and estimands. RESULTS: One thousand five hundred and forty-one articles were identified by the initial search. Following screening, 146 articles were identified as meeting the eligibility criteria. Of the eligible articles, five (3%) stated their primary estimand, and of these, three (2%) stated all five estimand attributes. Ninety-four (64%) articles described one or more intercurrent events; these included a total of two hundred and thirty-two intercurrent events described. Fifty-two (36%) articles did not describe any intercurrent events. No articles specified the estimand for any planned interim analyses or considered the implications of adaptations on the primary estimand. CONCLUSIONS: This review provides evidence that there is still a lack of uptake of the estimand framework in RCTs. Wider application of the estimand framework would ensure clarity in the reporting and interpretation of clinical trial results. In addition, clear guidance on how to implement the estimand framework to trials with an adaptive design is needed.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Piazza F, Wallace H, Phillips R, et al. Investigating estimand considerations in adaptive trials: a systematic review. Trials. 2026. PMID: 41645316. doi:10.1186/s13063-026-09490-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。